Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Society of Cardiology

This page shows the latest European Society of Cardiology news and features for those working in and with pharma, biotech and healthcare.

Real-world data finds patients feel better on Entresto, says Novartis

Real-world data finds patients feel better on Entresto, says Novartis

The real-world data - reported at the European Society of Cardiology Heart Failure (ESC-HF) Congress over the weekend - comes from the CHAMP-HF registry of heart failure patients and specifically ... According to CHAMP-HF Chair Gregg Fonarow of UCLA's

Latest news

  • FDA approves first Apple Watch medical device accessory FDA approves first Apple Watch medical device accessory

    In September, AliveCor presented data from studies at the European Society of Cardiology Congress In Barcelona showing that patients using Kardia Mobile were four times more likely to have their AF ... detected, and that the diagnostic accuracy of the

  • Merck & Co's anacetrapib data fails to generate much excitement Merck & Co's anacetrapib data fails to generate much excitement

    Back in June, Merck announced that anacetrapib had achieved its primary endpoint in REVEAL, reducing MACE - a composite of coronary death, myocardial infarction and coronary revascularisation - compared with placebo in patients ... This week, Merck

  • Novartis and Bayer among backers for European big data project Novartis and Bayer among backers for European big data project

    Its overarching aim is to improve patient outcomes and reduce the burden on society of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS). ... As part of that the partners, which also include University Medical Center Utrecht,

  • Merck & Co's anacetrapib rescued by positive phase III trial Merck & Co's anacetrapib rescued by positive phase III trial

    A final decision on commercialisation will likely depend on the magnitude of the benefit on MACE in REVEAL. ... For now, that data is under wraps but cardiologists will get a chance to pore over the numbers when REVEAL is presented at the European

  • CV data sets up Novartis' Ilaris for blockbuster sales CV data sets up Novartis' Ilaris for blockbuster sales

    There is still some way to go before approval - including presenting the data to cardiologists (most likely at the European Society of Cardiology Congress in August) - and discussing with regulators what ... Even if approved, Novartis' experience with

More from news
Approximately 2 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Is it possible to change behaviour virtually? Is it possible to change behaviour virtually?

    One of my colleagues, Emma, has also incorporated virtual technology into a medical education programme. ... What value did the virtual mannequin add?  . It was the first time ever a virtual mannequin had been used at the European Society of Cardiology

  • Helping European cardiologists keep up to date Helping European cardiologists keep up to date

    But when asked about their propensity to take part in programmes in relation to: (1) the sponsoring organisation (independent bodies such as the European Society of Cardiology or an unrestricted grant ... Figure 4: EU5 average of preferences of online

  • Change drivers: multi-stakeholder education and collaboration Change drivers: multi-stakeholder education and collaboration

    Professor John Camm, Chair of the European Society of Cardiology Committee for Guidelines on the Management of Atrial Fibrillation told me recently: “Well-meaning rewording of key messages to 'suit' different ... It resulted in improved cholesterol

  • Closing the treatment gap

    Timescale:March 2009 to August 2009. The annual European Society of Cardiology Congress is the largest global cardiology meeting, attracting thousands of delegates and hundreds of journalists; the competition between pharmaceutical ... Merck, with a

  • A very favourable verdict

    Timescale:July 2009 to December 2009. Guest delegates of DAIICHI SANKYO UK at the European Society of Cardiology Congress were subpoenaed to appear on a jury at The Formulary Court of ... meetings and will also roll out via a series of regional GP

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Conference research case study

    Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress. ... meant to our clients key customers and the overall impact of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Quick links

Infographics

Multimedia